These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 37371076)

  • 1. The Role of CD36 in Cancer Progression and Its Value as a Therapeutic Target.
    Feng WW; Zuppe HT; Kurokawa M
    Cells; 2023 Jun; 12(12):. PubMed ID: 37371076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamic role of the transmembrane glycoprotein CD36 (SR-B2) in cellular fatty acid uptake and utilization.
    Glatz JFC; Luiken JJFP
    J Lipid Res; 2018 Jul; 59(7):1084-1093. PubMed ID: 29627764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD36 palmitoylation disrupts free fatty acid metabolism and promotes tissue inflammation in non-alcoholic steatohepatitis.
    Zhao L; Zhang C; Luo X; Wang P; Zhou W; Zhong S; Xie Y; Jiang Y; Yang P; Tang R; Pan Q; Hall AR; Luong TV; Fan J; Varghese Z; Moorhead JF; Pinzani M; Chen Y; Ruan XZ
    J Hepatol; 2018 Sep; 69(3):705-717. PubMed ID: 29705240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD36: The Bridge between Lipids and Tumors.
    Zhou X; Su M; Lu J; Li D; Niu X; Wang Y
    Molecules; 2024 Jan; 29(2):. PubMed ID: 38276607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD36, a signaling receptor and fatty acid transporter that regulates immune cell metabolism and fate.
    Chen Y; Zhang J; Cui W; Silverstein RL
    J Exp Med; 2022 Jun; 219(6):. PubMed ID: 35438721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD36 tango in cancer: signaling pathways and functions.
    Wang J; Li Y
    Theranostics; 2019; 9(17):4893-4908. PubMed ID: 31410189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD36: an emerging therapeutic target for cancer and its molecular mechanisms.
    Ruan C; Meng Y; Song H
    J Cancer Res Clin Oncol; 2022 Jul; 148(7):1551-1558. PubMed ID: 35224665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interplay of CD36, autophagy, and lipid metabolism: insights into cancer progression.
    Yang Y; Liu X; Yang D; Li L; Li S; Lu S; Li N
    Metabolism; 2024 Jun; 155():155905. PubMed ID: 38548128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD36 as a double-edged sword in cancer.
    Jiang M; Karsenberg R; Bianchi F; van den Bogaart G
    Immunol Lett; 2024 Feb; 265():7-15. PubMed ID: 38122906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The regulatory role of CD36 in hematopoiesis beyond fatty acid uptake.
    Ashaq MS; Zhang S; Xu M; Li Y; Zhao B
    Life Sci; 2024 Feb; 339():122442. PubMed ID: 38244916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The enigmatic membrane fatty acid transporter CD36: New insights into fatty acid binding and their effects on uptake of oxidized LDL.
    Jay AG; Hamilton JA
    Prostaglandins Leukot Essent Fatty Acids; 2018 Nov; 138():64-70. PubMed ID: 27288302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD36-mediated metabolic crosstalk between tumor cells and macrophages affects liver metastasis.
    Yang P; Qin H; Li Y; Xiao A; Zheng E; Zeng H; Su C; Luo X; Lu Q; Liao M; Zhao L; Wei L; Varghese Z; Moorhead JF; Chen Y; Ruan XZ
    Nat Commun; 2022 Oct; 13(1):5782. PubMed ID: 36184646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD36 (SR-B2) as master regulator of cellular fatty acid homeostasis.
    Glatz JFC; Nabben M; Luiken JJFP
    Curr Opin Lipidol; 2022 Apr; 33(2):103-111. PubMed ID: 35125400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD36 as a target for metabolic modulation therapy in cardiac disease.
    Glatz JFC; Wang F; Nabben M; Luiken JJFP
    Expert Opin Ther Targets; 2021 May; 25(5):393-400. PubMed ID: 34128755
    [No Abstract]   [Full Text] [Related]  

  • 15. Fatty-acid receptor CD36 functions as a hydrogen sulfide-targeted receptor with its Cys333-Cys272 disulfide bond serving as a specific molecular switch to accelerate gastric cancer metastasis.
    Wang R; Tao B; Fan Q; Wang S; Chen L; Zhang J; Hao Y; Dong S; Wang Z; Wang W; Cai Y; Li X; Bao T; Wang X; Qiu X; Wang K; Mo X; Kang Y; Wang Z
    EBioMedicine; 2019 Jul; 45():108-123. PubMed ID: 31262715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD36 and Its Role in Regulating the Tumor Microenvironment.
    Liao X; Yan S; Li J; Jiang C; Huang S; Liu S; Zou X; Zhang G; Zou J; Liu Q
    Curr Oncol; 2022 Oct; 29(11):8133-8145. PubMed ID: 36354702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD36 as a gatekeeper of myocardial lipid metabolism and therapeutic target for metabolic disease.
    Glatz JFC; Heather LC; Luiken JJFP
    Physiol Rev; 2024 Apr; 104(2):727-764. PubMed ID: 37882731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ligand-dependent CD36 functions in cancer progression, metastasis, immune response, and drug resistance.
    Xia L; Zhou Z; Chen X; Luo W; Ding L; Xie H; Zhuang W; Ni K; Li G
    Biomed Pharmacother; 2023 Dec; 168():115834. PubMed ID: 37931517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD36-Fatty Acid-Mediated Metastasis via the Bidirectional Interactions of Cancer Cells and Macrophages.
    Zaidi NE; Shazali NAH; Leow TC; Osman MA; Ibrahim K; Cheng WH; Lai KS; Nik Abd Rahman NMA
    Cells; 2022 Nov; 11(22):. PubMed ID: 36428985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD36-Mediated Metabolic Rewiring of Breast Cancer Cells Promotes Resistance to HER2-Targeted Therapies.
    Feng WW; Wilkins O; Bang S; Ung M; Li J; An J; Del Genio C; Canfield K; DiRenzo J; Wells W; Gaur A; Robey RB; Guo JY; Powles RL; Sotiriou C; Pusztai L; Febbraio M; Cheng C; Kinlaw WB; Kurokawa M
    Cell Rep; 2019 Dec; 29(11):3405-3420.e5. PubMed ID: 31825825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.